Recent Fundamentals:: Tonix Pharmaceuticals Holding Corp., (NASDAQ: TNXP)

 

On Monday, November 16, 2020, the Company, Tonix Pharmaceuticals Holding Corp., TNXP stock construct a change of -2.09 percent (Loss) in a total of its share price and having its trading value $0.61, which belongs to Healthcare sector and Biotechnology industry. The company?s Market capitalization was $88.11M with the total Outstanding Shares of 156.58M.

 


P/S, P/E, P/B & P/C values of (NASDAQ: TNXP):

 

Tonix Pharmaceuticals Holding Corp. institutional ownership is standing at 3.9 percent, while insider ownership is 0.05 percent. As of now, TNXP has a P/S, P/E and, P/B values of 0, 0, and 1.23 respectively. Its P/Cash is valued at 1.58.

 

The stock SMA50 is now at -17.59 percent. In looking, the SMA 200 we see that the stock has seen a -23.57 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 0 percent.


Profitability ratios:

 

Looking into the profitability ratios of TNXP stock, an investor will find its ROE, ROA, ROI standing at 0 percent, 0 percent and, 0 percent, respectively.


Beta Factor:

 

A beta factor is used to measure the volatility of the stock. The stock remaining at 8.9 percent volatile for the week and 7.42 percent for the month.


Gross / Operating Margins of TNXP:

 

It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 0 percent & Operating Margin seen at 0 percent.


Target Price:

 

Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Tonix Pharmaceuticals Holding Corp. recorded it at $0.


Historical Performance In The News:

 

Taking a look at the performance of Tonix Pharmaceuticals Holding Corp. stock, an investor will come to know that the weekly performance for this stock is valuing at 14.13 percent, resulting in a performance for the month at -18.03 percent.

Therefore, the stated figure displays a quarterly performance of -38.72 percent, bringing six-month performance to -14.06 percent and year to date performance of -48.29 percent. As of now, Tonix Pharmaceuticals Holding Corp. has a P/S, P/E and, P/B values of 0, 0, and 1.23 respectively. Its P/Cash is valued at 1.58.


Earnings per Share Details of Tonix Pharmaceuticals Holding Corp.:

 

The EPS of TNXP is strolling at -59.29, measuring its EPS growth this year at 92.8 percent. As a result, the company has an EPS growth of 37.9 percent for the approaching year.